All Articles tagged patients

Brief Report
November 27, 2024 EDT
Could the Inflation Reduction Act Maximum Fair Price Hurt Patients?
Anne M. SydorEsteban RiveraRobert Popovian
This brief report presents a model that evaluates how increased out-of-pocket costs for the anticoagulants apixaban (Eliquis) and rivaroxaban (Xarelto) could impact patients financially and clinically.
$Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure$ Cardiovascular Conditions
February 20, 2024 EDT
Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure
Alpesh N. AminAlex KartashovWilson NgaiKevin SteeleNing Rosenthal
This study compared the effectiveness, safety, and costs of enoxaparin vs unfractionated heparin thromboprophylaxis in medical inpatients with chronic obstructive pulmonary disease or heart failure.